Literature DB >> 9950213

Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III.

X Deng1, S Bellis, Z Yan, E Friedman.   

Abstract

The two major intestinal epithelial cell lineages are columnar fluid-absorbing cells and mucin-producing goblet cells. High levels of transforming growth factor (TGF) beta1 are found surrounding postmitotic cells in the colonic crypt, suggesting that TGF-beta1 mediates the maturation and growth inhibition of both epithelial cell types. However, we now show that the injection of recombinant TGF-beta1 into mice leads to an enrichment of goblet cells, indicating that these normal epithelial cells are resistant to TGF-beta1. In support of this interpretation, each of two independently isolated cell lines modeling normal colon goblet cells was also growth resistant to exogenous TGF-beta1 but made levels of TGF-beta receptor (TbetaR) I, TbetaRII, and TbetaIII mRNA and protein equal to those made by two TGF-beta1-sensitive cell lines. No mutations were found in the alk5 or alk2 forms of TbetaRI or in TbetaRII; these receptors were found on the cell surface, although they could not bind 125I-labeled TGF-beta1. TbetaRIII binds TGF-beta1, concentrates it, and presents it to TbetaRII. The major TbetaRIII form, betaglycan, did not undergo normal posttranslational modification in either of the goblet cell lines and could not bind 125I-labeled TGF-beta1; thus, it was nonfunctional. TGF-beta resistance was overcome by raising TGF-beta1 levels 100-fold, at which point TbetaRII could bind TGF-beta1. Signaling initiated by these higher TGF-beta1 levels was blocked by the expression of dominant negative TbetaRII, demonstrating that TbetaRII and TbetaRI were functional. Cells resistant to exogenous TGF-beta1 maintained functional cell surface TbetaRI and TbetaRII to mediate responses to autocrine TGF-beta1, which controlled the maturation of the adhesion protein integrin beta1. Expression of dominant negative TbetaRII in goblet cells greatly inhibited the conversion of the beta1 integrin from its precursor to its mature form. Thus, in normal intestinal epithelial goblet cells, TbetaRI and TbetaRII can respond to autocrine but not exogenous TGF-beta without the participation of TbetaRIII. Absorptive epithelial cells are growth inhibited by TGF-beta1 both in vivo and in vitro; therefore, the loss of functional TbetaRIIIs on goblet cells allows differential regulation of the two major intestinal epithelial cell types.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9950213

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  12 in total

1.  Changes in expression of genes related to cell proliferation in human mesenchymal stem cells during in vitro culture in comparison with cancer cells.

Authors:  Rumi Sawada; Tomomi Ito; Toshie Tsuchiya
Journal:  J Artif Organs       Date:  2006       Impact factor: 1.731

2.  Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.

Authors:  Catherine E Gatza; Alisha Holtzhausen; Kellye C Kirkbride; Allyson Morton; Michael L Gatza; Michael B Datto; Gerard C Blobe
Journal:  Neoplasia       Date:  2011-08       Impact factor: 5.715

Review 3.  Roles for the type III TGF-beta receptor in human cancer.

Authors:  Catherine E Gatza; Sun Young Oh; Gerard C Blobe
Journal:  Cell Signal       Date:  2010-02-12       Impact factor: 4.315

4.  Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells.

Authors:  A Wimmel; B Wiedenmann; S Rosewicz
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

5.  Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos.

Authors:  Kaye L Stenvers; Melinda L Tursky; Kenneth W Harder; Nicole Kountouri; Supavadee Amatayakul-Chantler; Dianne Grail; Clayton Small; Robert A Weinberg; Andrew M Sizeland; Hong-Jian Zhu
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

6.  The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.

Authors:  Hye Jin You; Tam How; Gerard C Blobe
Journal:  Carcinogenesis       Date:  2009-03-26       Impact factor: 4.944

7.  Endocytosis of the type III transforming growth factor-beta (TGF-beta) receptor through the clathrin-independent/lipid raft pathway regulates TGF-beta signaling and receptor down-regulation.

Authors:  Elizabeth C Finger; Nam Y Lee; Hye-jin You; Gerard C Blobe
Journal:  J Biol Chem       Date:  2008-10-08       Impact factor: 5.157

8.  Mirk regulates the exit of colon cancer cells from quiescence.

Authors:  Kideok Jin; Daina Z Ewton; Sunju Park; Jing Hu; Eileen Friedman
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

9.  The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42.

Authors:  Karthikeyan Mythreye; Gerard C Blobe
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-01       Impact factor: 11.205

10.  Induction of transforming growth factor beta receptors following focal ischemia in the rat brain.

Authors:  Gabriella Pál; Gábor Lovas; Arpád Dobolyi
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.